There is currently no text in this page. You can search for this page title in other pages, or search the related logs, but you do not have permission to create this page.
Category:BIOGEN MA INC.
Pages in category "BIOGEN MA INC."
The following 12 pages are in this category, out of 12 total.
2
- 20240051917. HETEROCYCLIC SULFONAMIDES, USES AND PHARMACEUTICAL COMPOSITIONS THEREOF simplified abstract (BIOGEN MA INC.)
- 20250152574. Emopamil-binding Protein Inhibi (BIOGEN MA .)
- 20250152574. Emopamil-binding Protein Inhibi (BIOGEN MA INC.)
- 20250161281. Emopamil-binding Protein Inhibi (BIOGEN MA .)
- 20250164486. Method Assessing Risk Pml (BIOGEN MA .)
- 20250171463. Emopamil-binding Protein Inhibi (BIOGEN MA .)
B
- BIOGEN MA INC. (20250152574). EMOPAMIL-BINDING PROTEIN INHIBITORS AND USES THEREOF
- BIOGEN MA INC. Patent Application Trends in 2025
- Blockchain patent applications on April 11th, 2024
- Blockchain patent applications on April 4th, 2024
- Blockchain patent applications on February 15th, 2024
- Blockchain patent applications on March 14th, 2024